Warner Chilcott Plc and some non- executive employees received a subpoena from the U.S. Attorney’s Office in Massachusetts for information on a “wide range of matters,” including its sales and marketing practices. The Feb. 22 subpoena seeks information on payments to people who are in a position to recommend drugs, medical education, clinical trials, off-label use and employee training for key products, the Dublin-based company said today in a filing with the U.S. Securities and Exchange Commission.
